Drug Discovery · London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. Valink Therapeutics is based in London, United Kingdom and was founded in 2020. It was valued at $12.6 million at its seed round in Nov 2023, the last priced event on record. It has raised $20.5 million across 1 recorded round; the latest was a $7.6 million seed round in Nov 2023.
PMV mark · valuation
$12.6M
Oct 2026
Priced at
its seed round
Nov 2023
Total raised
$20.5M
Last round
Seed Round
Nov 2023
Cap table — not yet on record
Valink Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Valink Therapeutics with a free account
·The complete investor list: 18 names
·Watch Valink Therapeutics: the Monday email on marks, rounds and moves
Where does Valink Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Valink Therapeutics's 1 recorded funding rounds.
